iTeos Therapeutics to join S&P SmallCap 600


NEW YORK, December 31, 2021 / PRNewswire / – iTeos Therapeutics Inc. (NASD: ITOS) will replace Magellan Health Inc. (NASD: MGLN) in the S&P SmallCap 600 upon opening of trading on Wednesday 5 January. Centene Corp. (NYSE: CNC), a constituent of the S&P 500, is acquiring Magellan Health in a deal expected to close shortly pending final terms.

Here is a summary of the changes that will take place prior to market opening on the Effective Date:

Effective date Index name action Company Name Teleprinter GICS sector
January 5, 2022 S&P Small Cap 600 Addition iTeos Therapeutics ITOS Health care
S&P Small Cap 600 Erasure Magellan Health MGLN Health care

For more information on the S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the world’s largest resource for essential index-based concepts, data and research, and is home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than in products based on indices from any other provider in the world. Because Charles Dow Invented the first index in 1884, S&P DJI innovated and developed indices across the spectrum of asset classes helping to define how investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential information to individuals, businesses and governments to make confident decisions. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
[email protected]

Media inquiries
[email protected]

View original content: https://www.prnewswire.com/news-releases/iteos-therapeutics-set-to-join-sp-smallcap-600-301452438.html

SOURCE S&P Dow Jones Indices


Comments are closed.